Cardiovascular risk assessment and lipid modification

their healthcare provider so that their risk factors can be managed in the most effective way. Source guidance • Cardiovascular disease: risk assessment and reduction, including lipid modification. NICE guideline NG238 (2023), recommendations 1.1.1 to 1.1.4 • Cardiovascular disease: identifying and supporting people most at risk of dying early. NICE guideline PH15 (2008), recommendation 1 Definitions of terms used in this quality statement Factors routinely recorded in electronic patient records Factors routinely recorded in general practice patient records that could be used as part of a systematic strategy to identify adults with an increased CVD risk, include, but are not limited to: • age • sex • family history of CVD • ethnicity • smoking status • presence of other conditions known to associate with higher CVD risk such as diabetes, chronic kidney disease, atrial fibrillation, rheumatoid arthritis, systemic lupus erythematosus, severe mental illness, migraine and erectile dysfunction • use of antipsychotic, immunosuppressant or steroid medication • blood pressure • lipid levels • BMI. [Adapted from NICE's clinical knowledge summary on risk factors for CVD and expert opinion] Adults likely to be at high risk of CVD Adults with an estimated 10-year risk of CVD of 10% or more. [NICE's
